| Trial ID: | L4536 |
| Source ID: | NCT00451113
|
| Associated Drug: |
Sitagliptin 100 Mg
|
| Title: |
Sitagliptin in the Elderly
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Sitagliptin 100 mg
|
| Outcome Measures: |
Primary: Safety and efficacy of Sitagliptin in an elderly population with type 2 diabetes |
|
| Sponsor/Collaborators: |
Sponsor: University of British Columbia | Collaborators: Merck Frosst Canada Ltd.
|
| Gender: |
ALL
|
| Age: |
OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2006-11
|
| Completion Date: |
2012-11
|
| Results First Posted: |
|
| Last Update Posted: |
2018-01-18
|
| Locations: |
University of British Columbia Gerontology & Diabetes Research Centre, Vancouver, British Columbia, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT00451113
|
